Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 6.60x is in line with its 5-year average of 6.06x, near the high end of its 5-year range (-2.12x–9.72x).
As of the fiscal period ended Tuesday, March 31, 2026. 12.82% above its 12-month average of 5.85x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
6.60x
INTEREST COVERAGE RATIO AVG TTM
5.85x
INTEREST COVERAGE RATIO AVG 3Y
5.61x
INTEREST COVERAGE RATIO AVG 5Y
6.47x
INTEREST COVERAGE RATIO AVG 10Y
7.06x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+12.82%
CURRENT VS 3Y AVG
+17.75%
CURRENT VS 5Y AVG
+2.01%
CURRENT VS 10Y AVG
-6.44%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.77x
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
-2.47%
vs the sector median at left
AbbVie Inc.
Market Cap
$470.14B
Interest Coverage Ratio
6.60x
TTM Avg
5.85x
3Y Avg
5.61x
5Y Avg
6.47x
Market Cap
$385.65B
Interest Coverage Ratio
4.74x
TTM Avg
6.50x
3Y Avg
9.14x
5Y Avg
10.75x
Market Cap
$322.93B
Interest Coverage Ratio
17.31x
TTM Avg
16.61x
3Y Avg
13.70x
5Y Avg
12.98x
Market Cap
$643.64B
Interest Coverage Ratio
26.36x
TTM Avg
27.85x
3Y Avg
40.54x
5Y Avg
62.46x
Market Cap
$228.68B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$212.64B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$209.78B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$189.87B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
Market Cap
$166.24B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $470.14B | 6.60x | 5.85x | 5.61x | 6.47x |
| UnitedHealth Group Incorporated (UNH)vs › | $385.65B | 4.74x | 6.50x | 9.14x | 10.75x |
| Merck & Co., Inc. (MRK)vs › | $322.93B | 17.31x | 16.61x | 13.70x | 12.98x |
| Johnson & Johnson (JNJ)vs › | $643.64B | 26.36x | 27.85x | 40.54x | 62.46x |
| Novo Nordisk A/S (NVO)vs › | $228.68B | 30.34x | 54.30x | 123.94x | 139.58x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $212.64B | 5.71x | 5.17x | 6.77x | 10.10x |
| Amgen Inc. (AMGN)vs › | $209.78B | 3.88x | 3.09x | 3.93x | 4.89x |
| Abbott Laboratories (ABT)vs › | $189.87B | 23.60x | 17.46x | 17.67x | 16.77x |
| Gilead Sciences, Inc. (GILD)vs › | $166.24B | 11.43x | 6.56x | 7.26x | 7.18x |
| Pfizer Inc. (PFE)vs › | $143.68B | 5.78x | 5.55x | 10.96x | 11.04x |
Interest Coverage
6.6x
Debt/Equity
-21.12
Current Ratio
0.67
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 6.60x |
| 2025-12-31 | 8.14x |
| 2025-09-30 | 2.58x |
| 2025-06-30 | 6.61x |
| 2025-03-31 | 5.33x |
| 2024-12-31 | -2.12x |
| 2024-09-30 | 5.32x |
| 2024-06-30 | 5.51x |
| 2024-03-31 | 4.24x |
| 2023-12-31 | 5.66x |
| 2023-09-30 | 4.11x |
| 2023-06-30 | 8.18x |
| 2023-03-31 | 5.01x |
| 2022-12-31 | 9.72x |
| 2022-09-30 | 8.22x |
| 2022-06-30 | 5.93x |
| 2022-03-31 | 8.61x |
| 2021-12-31 | 8.75x |
| 2021-09-30 | 7.22x |
| 2021-06-30 | 7.22x |
| 2021-03-31 | 6.49x |
| 2020-12-31 | 5.97x |
| 2020-09-30 | 5.17x |
| 2020-06-30 | 1.19x |
| 2020-03-31 | 6.40x |
| 2019-12-31 | 7.08x |
| 2019-09-30 | 5.45x |
| 2019-06-30 | 9.50x |
| 2019-03-31 | 7.78x |
| 2018-12-31 | -6.42x |
| 2018-09-30 | 9.32x |
| 2018-06-30 | 8.63x |
| 2018-03-31 | 9.39x |
| 2017-12-31 | 6.00x |
| 2017-09-30 | 9.19x |
| 2017-06-30 | 9.37x |
| 2017-03-31 | 8.82x |
| 2016-12-31 | 7.46x |
| 2016-09-30 | 8.71x |
| 2016-06-30 | 9.74x |
| 2016-03-31 | 10.60x |
| 2015-12-31 | 10.16x |
| 2015-09-30 | 9.11x |
| 2015-06-30 | 10.77x |
| 2015-03-31 | 12.78x |
| 2014-12-31 | -2.99x |
| 2014-09-30 | 6.49x |
| 2014-06-30 | 20.75x |
| 2014-03-31 | 19.30x |
| 2013-12-31 | 20.74x |
| 2013-09-30 | 18.28x |
| 2013-06-30 | 18.39x |
| 2013-03-31 | 18.13x |
| 2012-09-30 | 159.60x |
